| （単位：千ドル） | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 2,932 | 3,235 | 3,564 | - | - | - | 25,108 | 16,231 | 16,100 | - | 29,311 | 40,314 | 41,278 |
| 営業費用 | 4,716 | 5,849 | 7,252 | - | - | - | 31,258 | 21,970 | 21,756 | - | 37,343 | 49,801 | 57,194 |
| 営業利益 | -4,716 | -5,849 | -7,252 | - | - | - | -31,258 | -21,970 | -21,756 | - | -37,343 | -49,801 | -57,194 |
| 純利益 | -4,714 | -3,437 | -7,611 | -17,085 | -14,853 | -24,679 | -30,069 | -20,162 | -20,104 | -28,383 | -33,708 | -46,632 | -51,694 |
| 一株あたり利益 | - | - | - | - | - | - | -0.8 | -0.46 | -0.45 | - | -0.62 | -0.85 | -0.81 |
| 希薄化後一株あたり利益 | - | - | - | - | - | - | -0.8 | -0.46 | -0.45 | - | -0.62 | -0.85 | -0.81 |
| EBITDA | - | - | - | - | - | - | - | - | - | - |